MedPath

Hubei Heyuan Gas Co.,Ltd.

Ownership
-
Established
2003-11-20
Employees
103
Market Cap
-
Website
https://www.hbhy-gas.com
Introduction

The company was founded in November 2003 and listed on the main board of the Shenzhen Stock Exchange in January 2020. It is now a national high-tech enterprise. The company has always been committed to R&D, production, sales, service and industrial exhaust recycling of various gas products. Its main business is divided into six major sectors: bulk gases, electronic specialty gases and electronic chemicals, new silicon-based functional materials, exhaust gas recovery, clean energy, industrial grade chemicals. The products serve a wide range of basic industries such as chemicals, steel, food, home appliances, machinery, etc., as well as emerging industries such as semiconductors, new energy, and biomedicine. Main products: nitrogen trifluoride, tungsten hexafluoride, hydrogen chloride, silicon tetrachloride, ethyl orthosilicate, silane coupling agent, electronic grade silane, industrial grade silane, industrial grade silane, high purity carbon monoxide, high purity carbon dioxide, high purity methane, high purity carbonyl sulfur, high purity ammonia, industrial grade ammonia, high purity chlorine gas, high purity hydrogen chloride, high purity hydrogen chloride, high purity hydrogen chloride, hydrogen bromide, boron trichloride, trimethylaluminum. Corporate honors: It was awarded the honorary title of “Top 50 Enterprises in China's Gas Industry in the 13th Five-Year Plan” by the China Industrial Gas Industry Association; the Yichang Municipal People's Government awarded the company the honorary title of the 5th “Yichang Three Gorges Quality Award”, and was selected as a “National Specialized and New 'Little Giant' Enterprise” by the Ministry of Industry and Information Technology. It won the honorary title of “Yichang Transportation Outstanding Contribution Enterprise”. Received the “Three Gorges Quality Award” honor. It was awarded the honorary titles of “Exclusive Supplier” and “Contributing Unit”.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Oxygen

Product Name
氧(液态)
Approval Number
国药准字H20093619
Approval Date
Feb 7, 2024
NMPA

Oxygen

Product Name
医用氧(气态)
Approval Number
国药准字H42022948
Approval Date
Sep 18, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.